----

----

| Cayman Islands(State or other jurisdiction of incorporation or organization)       |   | 98-1590223(I.R.S. Employer Identification No.) |
|------------------------------------------------------------------------------------|--------|------------------------------------------------|
|                                                                               |   |                                           |
| 9 West 57th Street, 39th FloorNew York, NY(Address of principal executive offices) |   | 10019(Zip Code)                           |
| Title of each class                                                                                                                             |   | TradingSymbol(s) |   | Name of each exchangeon which registered |
|-------------------------------------------------------------------------------------------------------------------------------------------------|--------|------------------|--------|------------------------------------------|
| Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant                            |   | SCUA.U           |   | New York Stock Exchange                  |
| Class A ordinary shares included as part of the units                                                                                           |   | SCUA             |   | New York Stock Exchange                  |
| Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 |   | SCUA WS          |   | New York Stock Exchange                  |

----

| Large accelerated filer ☐ | Accelerated filer ☐ | Non‐accelerated filer ☒ | Smaller reporting company ☒ | Emerging growth company ☒ |
|---------------------------------|---------------------------|-------------------------------------|-----------------------------------|---------------------------------|

----

----

| PART I     |     | 5                                                                                                                  |
|------------|----------|--------------------------------------------------------------------------------------------------------------------|
|       | Item 1.  | Business                                                                                                           | 5 |
|       | Item 1A. | Risk Factors                                                                                                       | 25 |
|       | Item 1B. | Unresolved Staff Comments                                                                                          | 68 |
|       | Item 2.  | Properties                                                                                                         | 68 |
|       | Item 3.  | Legal Proceedings                                                                                                  | 68 |
|       | Item 4.  | Mine Safety Disclosures                                                                                            | 68 |
| PART II    |     | 69                                                                                                                 |
|       | Item 5.  | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 69 |
|       | Item 6.  | [Reserved]                                                                                                         | 70 |
|       | Item 7.  | Management’s Discussion and Analysis of Financial Condition and Results of Operations                        | 70 |
|       | Item 7A. | Quantitative and Qualitative Disclosures About Market Risk                                                         | 74 |
|       | Item 8.  | Financial Statements and Supplementary Data                                                                        | 74 |
|       | Item 9.  | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure                               | 75 |
|       | Item 9A. | Controls and Procedures                                                                                            | 75 |
|       | Item 9B. | Other Information                                                                                                  | 75 |
|       | Item 9C. | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections                                                |  75 |
| PART III   |     | 76                                                                                                                 |
|       | Item 10. | Directors, Executive Officers and Corporate Governance                                                             | 76 |
|       | Item 11. | Executive Compensation                                                                                             | 81 |
|       | Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters                     | 82 |
|       | Item 13. | Certain Relationships and Related Transactions, and Director Independence                                          | 83 |
|       | Item 14. | Principal Accountant Fees and Services                                                                             | 85 |
| PART IV    |     | 86                                                                                                                 |
|       | Item 15. | Exhibits and Financial Statement Schedules                                                                         | 86 |
|       | Item 16. | Form 10-K Summary                                                                                                  | 87 |
| SIGNATURES |     | 88                                                                                                                 |

----

Table                of Contents

|  | • | our ability to select an appropriate target business or businesses; |
|--|---------|---------------------------------------------------------------------|
|  | • | our ability to complete our initial business combination; |
|--|---------|-----------------------------------------------------------|
|  | • | our expectations around the performance of a prospective target business or businesses; |
|--|---------|-----------------------------------------------------------------------------------------|
|  | • | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our potential ability to obtain additional financing to complete our initial business combination; |
|--|---------|----------------------------------------------------------------------------------------------------|
|  | • | our pool of prospective target businesses; |
|--|---------|--------------------------------------------|
|  | • | our ability to consummate an initial business combination due to the continued uncertainty resulting from the COVID-19 pandemic; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------|
|  | • | the ability of our officers and directors to generate a number of potential business combination opportunities; |
|--|---------|-----------------------------------------------------------------------------------------------------------------|
|  | • | our public securities’ potential liquidity and trading; |
|--|---------|---------------------------------------------------------------|
|  | • | the lack of a market for our securities; |
|--|---------|------------------------------------------|
|  | • | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------|
|  | • | the trust account not being subject to claims of third parties; or |
|--|---------|--------------------------------------------------------------------|
|  | • | our financial performance following our initial public offering. |
|--|---------|------------------------------------------------------------------|

----

Table                of Contents

|  | • | We are a company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Past performance by Sculptor Capital Management, Inc. (“Sculptor” or “Sculptor Capital”) and the  Sculptor Funds (as defined below), as well as our management team, directors and advisors, is not indicative of future performance of an                investment in the company or in the future performance of any business we may acquire. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Our shareholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete our initial business combination even though a majority of our shareholders do not support such a                combination. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Your only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash. |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | If we seek shareholder approval of our initial business combination, our sponsor and members of our management team have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote. |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with                a target. |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait                for liquidation in order to redeem your shares. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | The requirement that we consummate an initial business combination within the completion window (as defined below) may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have                in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce                value for our shareholders. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the recent coronavirus (COVID-19) outbreak and the status of debt and                equity markets. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | We may not be able to consummate an initial business combination within the completion window, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | If we seek shareholder approval of our initial business combination, our sponsor, directors, executive officers, advisors and their affiliates may elect to purchase public shares or warrants, which may influence a vote on a proposed                business combination and reduce the public “float” of our Class A ordinary shares or public warrants. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

|  | • | If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed. |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a                loss. |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | The New York Stock Exchange (the “NYSE”) may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | The nominal purchase price paid by our sponsor for the founder shares may significantly dilute the implied value of your public shares in the event we complete an initial business combination. In addition, the value of the sponsor’s                founder shares will be significantly greater than the amount our sponsor paid to purchase such shares in the event we complete an initial business combination, even if the business combination causes the trading price of our Class A                ordinary shares to materially decline. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | You will not be entitled to protections normally afforded to investors of many other blank check companies. |
|--|---------|-------------------------------------------------------------------------------------------------------------|
|  | • | If we seek shareholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of shareholders are deemed to hold in excess of 15% of our Class A ordinary                shares, you will lose the ability to redeem all such shares in excess of 15% of our Class A ordinary shares. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we have not consummated our initial business                combination within the required time period, our public shareholders may receive only approximately $10.20 per public share (or $10.30, $10.40 or $10.50 per share, as applicable, if we extend the completion window), or less in certain                circumstances, on the liquidation of our trust account and our warrants will expire worthless. |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | If the net proceeds of our initial public offering and the sale of the private placement warrants not being held in the trust account are insufficient to allow us to operate for the completion window, it could limit the amount available                to fund our search for a target business or businesses and our ability to complete our initial business combination, and we will depend on loans from our sponsor, its affiliates or members of our management team to fund our search and to                complete our initial business combination. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | We have the right to extend the term we have to consummate our initial business combination up to three times, each time for an additional 3 months. Public shareholders will not be offered the opportunity to vote on or redeem their                shares in connection with any such paid extension. |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | The other risks and uncertainties discussed in “Risk Factors” and elsewhere in this Form 10-K. |
|--|---------|------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

| ITEM 1. | BUSINESS. |
|---------|-----------|

----

Table                of Contents

----

Table                of Contents

|  | • | Breadth of Experience. Throughout Sculptor Real Estate’s history, it has invested in 24 different real estate asset classes and has shifted its focus between traditional and non-traditional asset                classes based on where it has found the most compelling opportunities at different points in time. It was this strategy that led Sculptor Real Estate to generate above market returns during the Global Financial Crisis of 2007-2008 by                finding compelling opportunistic investments in less correlated, non-traditional real estate asset classes, such as cellular towers and Native American gaming. Similarly, after a rebound in market conditions following the Global Financial                Crisis, this same strategy led Sculptor Real Estate to target less correlated, real estate-related asset classes, such as drive-to ski, golf, marina and stadium and exhibition. |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Extensive Network. Sculptor Real Estate has one of the real estate industry’s most diverse networks of strategic partners, including advisors, directors, operators, consultants and capital                providers, across each of the 25 real estate-related asset classes in which it has invested as well as the new sectors that it is constantly exploring. We will utilize Sculptor Real Estate’s extensive network by tapping into the collective                talent, expertise, and entrepreneurism of its relationships, which provides access to technology-augmented, high growth businesses on the forefront of space utilization, experiential consumer trends and innovative services. |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

|  | • | Operational Expertise. Since inception, Sculptor Real Estate has focused on certain investment strategies that leverage Sculptor Real Estate’s operational expertise, the possession of which has                allowed Sculptor Real Estate to differentiate itself from other capital providers and to secure proprietary deal flow. Historically, this has included a wide range of investment strategies, including homebuilding, cell towers, cold chain                logistics, senior care, Native American casinos, distributed gaming, stadium and exhibition, outdoor leisure, and various others. We expect to benefit from the continued application of, and differentiation provided by, the operating                expertise that the Sculptor Real Estate platform has developed. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Team Continuity. The senior members of Sculptor Real Estate’s team have been working together since Sculptor Real Estate’s first fund in 2005, enhancing consistency in sourcing, underwriting,                structuring, diligence, and, most importantly, returns. Sculptor Real Estate has historically been able to attract and retain top talent by providing exceptional development opportunities by allowing team members to take ownership over                certain asset classes or product types. The historic increase in the size of Sculptor Real Estate’s funds has been driven by the growth of its team and its capabilities, not vice versa. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Sculptor Platform. We will seek to leverage the full breadth of Sculptor’s investment platform, which we believe will provide a competitive advantage over other blank check companies that do not                enjoy similar benefits from having a deep relationship with a diverse global asset management platform. Sculptor’s 100+ investment professionals and their comprehensive network of business contacts with leading financial institutions and                major multinational corporations have proven valuable in sourcing, evaluating and managing investments throughout its history. Moreover, Sculptor’s extensive capital markets presence, “cross-pollination” of credit, private investment,                public markets and real estate investment disciplines, risk management abilities, public company infrastructure and controls and Sculptor’s “One Firm” culture have allowed Sculptor to quickly identify and capitalize on differentiated                investment trends and opportunities across multiple sectors. |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Innovative, market-leading companies that are positioned to create sustainable competitive advantages; |
|--|---------|--------------------------------------------------------------------------------------------------------|
|  | • | Strong management teams with a proven track record establishing and growing businesses; |
|--|---------|-----------------------------------------------------------------------------------------|
|  | • | Ability to deliver strong revenue growth and profitable unit economics; |
|--|---------|-------------------------------------------------------------------------|
|  | • | Shared vision that will benefit from Sculptor’s operating and capital markets expertise and differentiated industry network; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Will benefit from access to capital in order to accelerate growth and shareholder value creation; and |
|--|---------|-------------------------------------------------------------------------------------------------------|
|  | • | Attractive valuations based on disciplined and highly informed underwriting that provide significant upside potential. |
|--|---------|------------------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

|  | • | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination; and |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
|--|---------|-------------------------------------------------------------------------------------------------------------|
|  | • | We issue ordinary shares that will be equal to or in excess of 20% of the number of our ordinary shares then-outstanding (other than in a public offering); |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Any of our directors, officers or substantial security holder (as defined by the NYSE rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or                assets to be acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in issued and outstanding ordinary shares or voting power of 5% or more; or |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

|  | • | The issuance or potential issuance of ordinary shares will result in our undergoing a change of control. |
|--|---------|----------------------------------------------------------------------------------------------------------|
|  | • | the timing of the transaction, including in the event we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or doing so would place the company at a disadvantage                in the transaction or result in other additional burdens on the company; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | the expected cost of holding a shareholder vote; |
|--|---------|--------------------------------------------------|
|  | • | the risk that the shareholders would fail to approve the proposed business combination; |
|--|---------|-----------------------------------------------------------------------------------------|
|  | • | other time and budget constraints of the company; and |
|--|---------|-------------------------------------------------------|
|  | • | additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to shareholders. |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

----

Table                of Contents

|  | • | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | file proxy materials with the SEC. |
|--|---------|------------------------------------|

----

Table                of Contents

|  | • | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------|
|  | • | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is                required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

| ITEM 1A. | RISK FACTORS. |
|----------|---------------|

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

|  | • | restrictions on the nature of our investments; and |
|--|---------|----------------------------------------------------|
|  | • | restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------|
|  | • | registration as an investment company with the SEC; |
|--|---------|-----------------------------------------------------|
|  | • | adoption of a specific form of corporate structure; and |
|--|---------|---------------------------------------------------------|
|  | • | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are currently not subject to. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

|  | • | may significantly dilute the equity interest of current investors, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than                one-to-one basis upon conversion of the Class B ordinary shares; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or                removal of our present officers and directors; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and |
|--|---------|-----------------------------------------------------------------------------------------------------------|
|  | • | may not result in adjustment to the exercise price of our warrants. |
|--|---------|---------------------------------------------------------------------|

----

Table                of Contents

----

Table                of Contents

|  | • | solely dependent upon the performance of a single business, property or asset; or |
|--|---------|-----------------------------------------------------------------------------------|
|  | • | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
|--|---------|-----------------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

|  | • | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver                or renegotiation of that covenant; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
|--|---------|--------------------------------------------------------------------------------------------------------|
|  | • | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | our inability to pay dividends on our Class A ordinary shares; |
|--|---------|----------------------------------------------------------------|
|  | • | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and                other general corporate purposes; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

|  | • | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------|
|  | • | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who                have less debt. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                of Contents

----

Table                of Contents

----

Table                of Contents

|  | • | costs and difficulties inherent in managing cross-border business operations; |
|--|---------|-------------------------------------------------------------------------------|
|  | • | rules and regulations regarding currency redemption; |
|--|---------|------------------------------------------------------|
|  | • | complex corporate withholding taxes on individuals; |
|--|---------|-----------------------------------------------------|
|  | • | laws governing the manner in which future business combinations may be effected; |
|--|---------|----------------------------------------------------------------------------------|

----

Table                of Contents

|  | • | exchange listing and/or delisting requirements; |
|--|---------|-------------------------------------------------|
|  | • | tariffs and trade barriers; |
|--|---------|-----------------------------|
|  | • | regulations related to customs and import/export matters; |
|--|---------|-----------------------------------------------------------|
|  | • | local or regional economic policies and market conditions; |
|--|---------|------------------------------------------------------------|
|  | • | unexpected changes in regulatory requirements; |
|--|---------|------------------------------------------------|
|  | • | longer payment cycles; |
|--|---------|------------------------|
|  | • | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
|--|---------|--------------------------------------------------------------------------------------------------|
|  | • | currency fluctuations and exchange controls; |
|--|---------|----------------------------------------------|
|  | • | rates of inflation; |
|--|---------|---------------------|
|  | • | challenges in collecting accounts receivable; |
|--|---------|-----------------------------------------------|
|  | • | cultural and language differences; |
|--|---------|------------------------------------|
|  | • | employment regulations; |
|--|---------|-------------------------|
|  | • | underdeveloped or unpredictable legal or regulatory systems; |
|--|---------|--------------------------------------------------------------|
|  | • | corruption; |
|--|---------|-------------|
|  | • | protection of intellectual property; |
|--|---------|--------------------------------------|
|  | • | social unrest, crime, strikes, riots and civil disturbances; |
|--|---------|--------------------------------------------------------------|
|  | • | regime changes and political upheaval; |
|--|---------|----------------------------------------|
|  | • | terrorist attacks, natural disasters, pandemics and wars; and |
|--|---------|---------------------------------------------------------------|
|  | • | deterioration of political relations with the United States. |
|--|---------|--------------------------------------------------------------|

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

|  | • | a limited availability of market quotations for our securities; |
|--|---------|-----------------------------------------------------------------|
|  | • | reduced liquidity for our securities; |
|--|---------|---------------------------------------|
|  | • | a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the                  secondary trading market for our securities; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | a limited amount of news and analyst coverage; and |
|--|---------|----------------------------------------------------|
|  | • | a decreased ability to issue additional securities or obtain additional financing in the future. |
|--|---------|--------------------------------------------------------------------------------------------------|

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

|  | • | we have a board that includes a majority of “independent directors,” as defined under the NYSE rules; |
|--|---------|-------------------------------------------------------------------------------------------------------------------|
|  | • | require a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | require a nominating and corporate governance committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                  of Contents

| Public shares                                                                                            |   |   | 23,000,000   |   |
|----------------------------------------------------------------------------------------------------------|--------|--------|--------------|--------|
| Founder shares                                                                                           |   |   | 5,750,000    |   |
| Total shares                                                                                             |   |   | 28,750,000   |   |
| Total funds in trust available for initial business combination (less deferred underwriting commissions) |   | $      | 226,550,000  |   |
| Public shareholders’ investment per Class A ordinary share(1)                                      |   | $      | ​10.20 |   |
| Our sponsor’s investment per Class B ordinary share(2)                                             |   | $      | 0.004        |   |
| Implied value per Class A ordinary share upon the initial business combination(3)                        |   | $      | 7.88         |   |
| (1) | While the public shareholders’ investment is in both the public shares and the public warrants, for purposes of this table the full investment amount is ascribed to the public shares                  only. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2) | The sponsor’s total investment in the equity of the Company, inclusive of the founder shares and the sponsor’s $11,200,000 investment in the private placement warrants, is $11,225,000.                |
| (3) | All founder shares held by our initial shareholders would automatically convert into Class A ordinary shares upon completion of our initial business combination.                                                   |

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

| ITEM 1B. | UNRESOLVED STAFF COMMENTS. |
|----------|----------------------------|
| ITEM 2. | PROPERTIES. |
|---------|-------------|
| ITEM 3. | LEGAL PROCEEDINGS. |
|---------|--------------------|
| ITEM 4. | MINE SAFETY DISCLOSURES |
|---------|-------------------------|

----

Table                  of Contents

| ITEM 5. | MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES. |
|---------|---------------------------------------------------------------------------------------------------------------------|

----

Table                  of Contents

| ITEM 6. | [RESERVED] |
|---------|------------|
| ITEM 7. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. |
|---------|----------------------------------------------------------------------------------------------|

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

| ITEM 7A. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. |
|----------|-------------------------------------------------------------|
| ITEM 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA. |
|---------|----------------------------------------------|

----

Table                  of Contents

| ITEM 9. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. |
|---------|---------------------------------------------------------------------------------------|
| ITEM 9A. | CONTROLS AND PROCEDURES. |
|----------|--------------------------|
| ITEM 9B. | OTHER INFORMATION. |
|----------|--------------------|
| ITEM 9C. | DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. |
|----------|----------------------------------------------------------------------|

----

Table                  of Contents

| ITEM 10. | DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. |
|----------|---------------------------------------------------------|
|   | Name            |    | Age |    | Position                          |
|--------|-----------------|---------|-----|---------|-----------------------------------|
|   | Steven Orbuch   | ​ | 55  | ​ | Chief Executive Officer, Director |
|   | Nicholas Hecker | ​ | 45  | ​ | Chief Investment Officer          |
|   | Dava Ritchea    | ​ | 37  | ​ | Chief Financial Officer           |
|   | James Levin     | ​ | 39  | ​ | Chairman, Director                |
|   | Wayne Cohen     | ​ | 47  | ​ | Director                          |
|   | Kristi Jackson  | ​ | 54  | ​ | Independent Director              |
|   | Charmel Maynard | ​ | 37  | ​ | Independent Director              |
|   | Adam Rosenberg  | ​ | 53  | ​ | Independent Director              |
|   | Ivy Zelman      | ​ | 55  | ​ | Independent Director              |

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

|  | • | meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | monitoring the independence of the independent registered public accounting firm; |
|--|---------|-----------------------------------------------------------------------------------|
|  | • | verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | inquiring and discussing with management our compliance with applicable laws and regulations; |
|--|---------|-----------------------------------------------------------------------------------------------|
|  | • | pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | appointing or replacing the independent registered public accounting firm; |
|--|---------|----------------------------------------------------------------------------|
|  | • | determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the                  purpose of preparing or issuing an audit report or related work; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting                  policies; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | monitoring compliance on a quarterly basis with the terms of our initial public offering and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance                  with the terms of our initial public offering; and |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | reviewing and approving all payments made to our existing shareholders, executive officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our board of                  directors, with the interested director or directors abstaining from such review and approval. |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                  of Contents

|  | • | should have demonstrated notable or significant achievements in business, education or public service; |
|--|---------|--------------------------------------------------------------------------------------------------------|
|  | • | should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders. |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and                  determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | reviewing and approving the compensation of all of our other Section 16 executive officers; |
|--|---------|---------------------------------------------------------------------------------------------|
|  | • | reviewing our executive compensation policies and plans; |
|--|---------|----------------------------------------------------------|
|  | • | implementing and administering our incentive compensation equity-based remuneration plans; |
|--|---------|--------------------------------------------------------------------------------------------|
|  | • | assisting management in complying with our proxy statement and annual report disclosure requirements; |
|--|---------|-------------------------------------------------------------------------------------------------------|
|  | • | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | producing a report on executive compensation to be included in our annual proxy statement; and |
|--|---------|------------------------------------------------------------------------------------------------|
|  | • | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
|--|---------|----------------------------------------------------------------------------------------------------|

----

Table                  of Contents

| ITEM 11. | EXECUTIVE COMPENSATION. |
|----------|-------------------------|

----

Table                  of Contents

| ITEM 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS. |
|----------|-------------------------------------------------------------------------------------------------|

|   | • | each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; |
|--------|---------|-------------------------------------------------------------------------------------------------------------------|

|   | • | each of our executive officers and directors that beneficially owns ordinary shares; and |
|--------|---------|------------------------------------------------------------------------------------------|

|   | • | all our executive officers and directors as a group. |
|--------|---------|------------------------------------------------------|

|                                                            |   | Class A Ordinary Shares          |      |      | Class B Ordinary Shares(2)    |   |    |                             |   |
|-----------------------------------------------------------------|--------|----------------------------------|-----------|-----------|-------------------------------|--------|---------|----------------------------------|--------|
| Name of BeneficialOwner(1)                                      |   | Number ofSharesBeneficiallyOwned |      |      | ApproximatePercentage ofClass |   |    | Number ofSharesBeneficiallyOwned |   |   | ApproximatePercentageof Class |   |   | ApproximatePercentage of Outstanding OrdinaryShares |   |
| Sculptor Acquisition Sponsor I (our sponsor)(3)                 |   |                             | 5,650,000 | (2)  |                          |   | 19.6    | %                                |   |   | 5,650,000 |   |   |   | 98.2 | % |   |   | 19.6 | % |
| Steven Orbuch                                                   |   |                             | —   |      |                          |   | — |                             |   |   | — |   |   |   | — |   |   |   | — |   |
| Nicholas Hecker                                                 |   |                             | —   |      |                          |   | — |                             |   |   | — |   |   |   | — |   |   |   | — |   |
| Dava Ritchea                                                    |   |                             | —   |      |                          |   | — |                             |   |   | — |   |   |   | — |   |   |   | — |   |
| James Levin                                                     |   |                             | —   |      |                          |   | — |                             |   |   | — |   |   |   | — |   |   |   | — |   |
| Wayne Cohen                                                     |   |                             | —   |      |                          |   | — |                             |   |   | — |   |   |   | — |   |   |   | — |   |
| Kristi Jackson                                                  |   |                             | 25,000    | (2)  |                          |   | *       |                             |   |   | 25,000 |   |   |   | * |   |   |   | * |   |
| Charmel Maynard                                                 |   |                             | 25,000    | (2)  |                          |   | *       |                             |   |   | 25,000 |   |   |   | * |   |   |   | * |   |
| Adam Rosenberg                                                  |   |                             | 25,000    | (2)  |                          |   | *       |                             |   |   | 25,000 |   |   |   | * |   |   |   | * |   |
| Ivy Zelman                                                      |   |                             | 25,000    | (2)  |                          |   | *       |                             |   |   | 25,000 |   |   |   | * |   |   |   | * |   |
| All executive officers and directors as a group (9 individuals) |   |                             | 5,750,000 |      |                          |   | 20      | %                                |   |   | 5,750,000 |   |   |   | 100 | % |   |   | 20 | % |
| Adage Capital Partners, L.P. (4)                                |   |                             | 1,700,000 |      |                          |   | 7.39    | %                                |   |   | — |   |   |   | — |   |   |   | 5.91 | % |

----

----

Table                  of Contents

| ITEM 13. | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE. |
|----------|----------------------------------------------------------------------------|

----

Table                  of Contents

----

Table                  of Contents

| ITEM 14. | PRINCIPAL ACCOUNTANT FEES AND SERVICES. |
|----------|-----------------------------------------|

----

Table                  of Contents

| ITEM 15. | EXHIBITS AND FINANCIAL STATEMENT SCHEDULES. |
|----------|---------------------------------------------|

|                                                                    | Page |
|-------------------------------------------------------------------------|------|
| Report of Independent Registered Public Accounting Firm (PCAOB ID #688) | F-2  |
| Balance Sheet                                                           | F-3  |
| Statement of Operations                                                 | F-4  |
| Statement of Changes in Shareholder’s Deficit                     | F-5  |
| Statement of Cash Flows                                                 | F-6  |
| Notes to Financial Statements                                           | F-7  |
|  | (2) | Financial Statement Schedules: |
|--|-----|--------------------------------|
|  | (3) | Exhibits |
|--|-----|----------|
| Exhibitnumber | Description of exhibit                                                                                                                                                          |
|---------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1           | Amended and Restated Memorandum and Articles of Association (1)                                                                                                                 |
|          |                                                                                                                                                                            |
| 4.1           | Warrant Agreement between Continental Stock Transfer & Trust Company and the Company (1)                                                                                    |
|          |                                                                                                                                                                            |
| 4.2           | Form of Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Form S-1, filed on October 15, 2021 (File No. 333-260302))                   |
|          |                                                                                                                                                                            |
| 4.3           | Form of Specimen Class A Ordinary Share Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Form S-1, filed on October 15, 2021 (File No. 333-260302)) |
|          |                                                                                                                                                                            |
| 4.4           | Form of Specimen Warrant Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Form S-1, filed on October 15, 2021 (File No. 333-260302))                |
|          |                                                                                                                                                                            |
| 4.5*          | Description of Registrant’s Securities                                                                                                                                    |
|          |                                                                                                                                                                            |
| 10.1          | Private Placement Warrants Purchase Agreement, dated December 8, 2021, between the Company and Sculptor Acquisition Sponsor I (1)                                               |
|          |                                                                                                                                                                            |
| 10.2          | Investment Management Trust Agreement, dated December 8, 2021, between the Company and Continental Stock Transfer & Trust Company (1)                                       |
|          |                                                                                                                                                                            |
| 10.3          | Registration and Shareholder Rights Agreement, dated December 8, 2021, between the Company and certain security holders (1)                                                     |
|          |                                                                                                                                                                            |
| 10.4          | Letter Agreement, dated December 8, 2021, between the Company, Sculptor Acquisition Sponsor I and each of the officers and directors of the Company (1)                         |
|          |                                                                                                                                                                            |

----

Table                  of Contents

| 10.5 | Form of Indemnity Agreement, dated December 8, 2021, between the Company and each of the officers and directors of the Company (1) |
|------|------------------------------------------------------------------------------------------------------------------------------------|
| 10.6     | Promissory Note, dated March 15, 2021, issued by the Company to Sculptor Acquisition Sponsor I (incorporated by reference to Exhibit 10.5 to the Company’s Form S-1, filed on October 15, 2021 (File No.                  333-260302))        |
|----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|     |                                                                                                                                                                                                                                                |
| 10.7     | Promissory Note, dated December 31, 2021, issued by the Company to Sculptor Acquisition Sponsor I (previously filed as an exhibit to our Current Report on Form 8-K filed on January 4, 2022 and incorporated                  by reference herein) |
|     |                                                                                                                                                                                                                                                |
| 31.1*    | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                              |
|     |                                                                                                                                                                                                                                                |
| 31.2*    | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                              |
|     |                                                                                                                                                                                                                                                |
| 32.1**   | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                                                              |
|     |                                                                                                                                                                                                                                                |
| 32.2**   | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                                                              |
|     |                                                                                                                                                                                                                                                |
| 101.INS* | XBRL Instance Document.                                                                                                                                                                                                                             |
|     |                                                                                                                                                                                                                                                |
| 101.SCH* | XBRL Taxonomy Extension Schema.                                                                                                                                                                                                                     |
|     |                                                                                                                                                                                                                                                |
| 101.CAL* | XBRL Taxonomy Extension Calculation Linkbase.                                                                                                                                                                                                       |
|     |                                                                                                                                                                                                                                                |
| 101.DEF* | XBRL Taxonomy Extension Definition Linkbase.                                                                                                                                                                                                        |
|     |                                                                                                                                                                                                                                                |
| 101.LAB* | XBRL Taxonomy Extension Label Linkbase.                                                                                                                                                                                                             |
|     |                                                                                                                                                                                                                                                |
| 101.PRE* | XBRL Taxonomy Extension Presentation Linkbase.                                                                                                                                                                                                      |
| * | Filed herewith. |
|---|-----------------|
| ** | Furnished herewith |
|----|--------------------|
| (1) | Previously filed as an exhibit to our Current Report on Form 8-K filed on December 13, 2021 (File No. 001-41142) and incorporated by reference herein. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------|
| ITEM 16. | FORM 10-K SUMMARY. |
|----------|--------------------|

----

Table                  of Contents

|   | SCULPTOR ACQUISITION CORP I |
|--------|-----------------------------|
|   |                        |
|   | By:                         | /s/ Steven Orbuch |
|   | Name:                       | Steven Orbuch |
|   | Title:                      | Chief Executive Officer |
| Signature           | Title                                        | Date           |
|---------------------|----------------------------------------------|----------------|
|                |                                         |           |
| /s/ Steven Orbuch   | Chief Executive Officer                      | March 28, 2022 |
| Steven Orbuch       | (Principal Executive Officer)                |           |
|                |                                         |           |
| /s/ Dava Ritchea    | Chief Financial Officer                      | March 28, 2022 |
| Dava Ritchea        | (Principal Financial and Accounting Officer) |           |
|                |                                         |           |
| /s/ James Levin     | Chairman                                     | March 28, 2022 |
| James Levin         |                                         |           |
|                |                                         |           |
| /s/ Wayne Cohen     | Director                                     | March 28, 2022 |
| Wayne Cohen         |                                         |           |
|                |                                         |           |
| /s/ Kristi Jackson  | Director                                     | March 28, 2022 |
| Kristi Jackson      |                                         |           |
|                |                                         |           |
| /s/ Charmel Maynard | Director                                     | March 28, 2022 |
| Charmel Maynard     |                                         |           |
|                |                                         |           |
| /s/ Adam Rosenberg  | Director                                     | March 28, 2022 |
| Adam Rosenberg      |                                         |           |
|                |                                         |           |
| /s/ Ivy Zelman      | Director                                     | March 28, 2022 |
| Ivy Zelman          |                                         |           |

----

Table                  of Contents

|                                                                    |   |
|-------------------------------------------------------------------------|--------|
|                                                                    | Page   |
| Audited Financial Statements                                            |   |
| Report of Independent Registered Public Accounting Firm (PCAOB ID #688) | F-2    |
| Balance Sheet                                                           | F-3    |
| Statement of Operations                                                 | F-4    |
| Statement of Changes in Shareholders’ Deficit                     | F-5    |
| Statement of Cash Flows                                                 | F-6    |
| Notes to Financial Statements                                           | F-7    |

----

Table                  of Contents

----

Table                  of Contents

| Assets                                                                                                                    |   |   |        |
|---------------------------------------------------------------------------------------------------------------------------|--------|--------|-------------|
| Current assets:                                                                                                           |   |   |        |
| Cash                                                                                                                      |   | $      | 941,792     |   |
| Prepaid expenses                                                                                                          |   |   | 23,767      |   |
| Total current assets                                                                                                      |   |   | 965,559     |   |
| Investments held in Trust Account                                                                                         |   |   | 234,600,723 |   |
| Total Assets                                                                                                              |   | $      | 235,566,282 |   |
|                                                                                                                      |   |   |        |   |
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit                       |   |   |        |   |
| Current liabilities:                                                                                                      |   |   |        |   |
| Accounts payable                                                                                                          |   | $      | 6,000       |   |
| Accrued expenses                                                                                                          |   |   | 157,111     |   |
| Total current liabilities                                                                                                 |   |   | 163,111     |   |
| Derivative warrant liabilities                                                                                            |   |   | 15,140,000  |   |
| Deferred underwriting fees                                                                                                |   |   | 8,050,000   |   |
| Total Liabilities                                                                                                         |   |   | 23,353,111  |   |
|                                                                                                                      |   |   |        |   |
| Commitments and Contingencies                                                                                             |   |   |        |   |
| Class A ordinary shares; 23,000,000 shares subject to possible redemption at $10.20 per share                             |   |   | 234,600,000 |   |
|                                                                                                                      |   |   |        |   |
| Shareholders’ Deficit:                                                                                              |   |   |        |   |
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding                  |   |   | -           |   |
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no non-redeemable shares issued or outstanding |   |   | -           |   |
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding         |   |   | 575         |   |
| Additional paid-in capital                                                                                                |   |   | -           |   |
| Accumulated deficit                                                                                                       |   |   | (22,387,404 | ) |
| Total Shareholders’ Deficit                                                                                         |   |   | (22,386,829 | ) |
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit                 |   | $      | 235,566,282 |   |

----

Table                  of Contents

| General and administrative expenses                                                        |   | $      | 219,095    |   |
|--------------------------------------------------------------------------------------------|--------|--------|------------|--------|
| Loss from operations                                                                       |   |   | (219,095   | )      |
|                                                                                       |   |   |       |   |
| Other income (expenses):                                                                   |   |   |       |   |
| Change in fair value of derivative warrant liabilities                                     |   |   | 15,378,000 |   |
| Loss upon issuance of private placement warrants                                           |   |   | (4,368,000 | )      |
| Income from investments held in Trust Account                                              |   |   | 723        |   |
| Offering costs associated with derivative warrant liabilities                              |   |   | (946,981   | )      |
| Net Income                                                                                 |   | $      | 9,844,647  |   |
|                                                                                       |   |   |       |   |
| Weighted average Class A ordinary shares subject to possible redemption, basic and diluted |   |   | 1,461,538  |   |
| Basic and diluted net income per ordinary share, Class A subject to possible redemption    |   | $      | 1.54       |   |
| Weighted average Class B ordinary shares, basic and diluted                                |   |   | 4,947,148  |   |
| Basic and diluted net income per ordinary share, Class B                                   |   | $      | 1.54       |   |

----

Table                  of Contents

|                                                       |   | Ordinary Shares |   |   | Additional Paid-in Capital |   |   | Accumulated Deficit |   |   | TotalShareholders’ Deficit |   |
|------------------------------------------------------------|--------|-----------------|--------|--------|----------------------------|--------|--------|---------------------|--------|--------|----------------------------------|--------|
|                                                       |   | Class A         |   |   | Class B                    |   |   |                |   |   |                             |   |
|                                                       |   | Shares          |   |   | Amount                     |   |   | Shares              |   |   | Amount                           |   |   |   |   |   |   |   |
| Balance – March 8, 2021 (inception)                  |   |            | -      |   |                       | $      | -      |                |   |   | -                                |   |   | $ | - |   |   | $ | - |   |   | $ | - |   |   | $ | - |   |
| Issuance of Class B ordinary shares to Sponsor             |   |            | -      |   |                       |   | -      |                |   |   | 5,750,000                        |   |   |   | 575 |   |   |   | 24,425 |   |   |   | - |   |   |   | 25,000 |   |
| Accretion for Class A ordinary shares to redemption amount |   |            | -      |   |                       |   | -      |                |   |   | -                                |   |   |   | - |   |   |   | (24,425 | ) |   |   | (32,232,051 | ) |   |   | (32,256,476 | ) |
| Net Income                                                 |   |            | -      |   |                       |   | -      |                |   |   | -                                |   |   |   | - |   |   |   | - |   |   |   | 9,844,647 |   |   |   | 9,844,647 |   |
| Balance – December 31, 2021                          |   |            | -      |   |                       | $      | -      |                |   |   | 5,750,000                        |   |   | $ | 575 |   |   | $ | - |   |   | $ | (22,387,404 | ) |   | $ | (22,386,829 | ) |

----

Table                  of Contents

| Cash Flows from Operating Activities:                                                                   |   |   |         |
|---------------------------------------------------------------------------------------------------------|--------|--------|--------------|
| Net income                                                                                              |   | $      | 9,844,647    |   |
| Adjustments to reconcile net income to net cash used in operating activities:                           |   |
| General and administrative expenses paid in exchange for issuance of Class B ordinary shares to Sponsor |   |   | 25,000       |   |
| General and administrative expenses paid by Sponsor under promissory note                               |   |   | 48,086       |   |
| Change in fair value of derivative warrant liabilities                                                  |   |   | (15,378,000  | ) |
| Loss upon issuance of private placement warrants                                                        |   |   | 4,368,000    |   |
| Offering costs associated with derivative warrant liabilities                                           |   |   | 946,981      |   |
| Income from investments held in Trust Account                                                           |   |   | (723         | ) |
| Changes in operating assets and liabilities:                                                            |   |   |         |   |
| Prepaid expenses                                                                                        |   |   | (23,767      | ) |
| Accounts payable                                                                                        |   |   | 6,000        |   |
| Accrued expenses                                                                                        |   |   | 72,111       |   |
| Net cash used in operating activities                                                                   |   |   | (91,665      | ) |
|                                                                                                    |   |   |         |   |
| Cash Flows from Investing Activities                                                                    |   |   |         |   |
| Cash deposited in Trust Account                                                                         |   |   | (234,600,000 | ) |
| Net cash used in investing activities                                                                   |   |   | (234,600,000 | ) |
|                                                                                                    |   |   |         |   |
| Cash Flows from Financing Activities:                                                                   |   |   |         |   |
| Repayment of promissory note to Sponsor                                                                 |   |   | (236,266     | ) |
| Proceeds received from initial public offering, gross                                                   |   |   | 230,000,000  |   |
| Proceeds received from private placement                                                                |   |   | 11,200,000   |   |
| Offering costs paid                                                                                     |   |   | (5,330,277   | ) |
| Net cash provided by financing activities                                                               |   |   | 235,633,457  |   |
|                                                                                                    |   |   |         |   |
| Net increase in cash                                                                                    |   |   | 941,792      |   |
|                                                                                                    |   |   |         |   |
| Cash - beginning of the period                                                                          |   |   | -            |   |
| Cash - end of the period                                                                                |   | $      | 941,792      |   |
|                                                                                                    |   |   |         |   |
| Supplemental disclosure of non-cash investing and financing activities:                                 |   |   |         |   |
| Offering costs included in accrued expenses                                                             |   | $      | 85,000       |   |
| Offering costs paid by Sponsor under promissory note                                                    |   | $      | 188,180      |   |
| Deferred underwriting fees                                                                              |   | $      | 8,050,000    |   |
| Accretion of Class A ordinary shares to redemption amount                                               |   | $      | 32,256,476   |   |

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

----

Table                  of Contents

|  | • | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------|
|  | • | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for                  identical or similar instruments in markets that are not active; and |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which                  one or more significant inputs or significant value drivers are unobservable. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                  of Contents

----

Table                  of Contents

|                                                            |   | For The Period From March 8, 2021 (Inception) Through December 31, 2021 |      |
|-----------------------------------------------------------------|--------|-------------------------------------------------------------------------|-----------|
|                                                            |   | Class A                                                                 |      |   | Class B |   |
| Numerator:                                                      |   |                                                                    |      |   |   |   |
| Allocation of net income                                        |   | $                                                                       | 2,245,129 |   |   | $ | 7,599,518 |   |
|                                                            |   |                                                                    |      |   |   |   |   |   |
| Denominator:                                                    |   |                                                                    |      |   |   |   |   |   |
| Weighted average ordinary shares outstanding, basic and diluted |   |                                                                    | 1,461,538 |   |   |   | 4,947,148 |   |
|                                                            |   |                                                                    |      |   |   |   |   |   |
| Basic and diluted net income per ordinary share                 |   | $                                                                       | 1.54      |   |   | $ | 1.54 |   |

----

Table                  of Contents

----

Table                  of Contents

|                                                                               |   |   |        |
|------------------------------------------------------------------------------------|--------|--------|-------------|
| Gross proceeds                                                                     |   | $      | 230,000,000 |   |
| Less:                                                                              |   |   |        |   |
| Proceeds allocated to Public Warrants                                              |   |   | (14,950,000 | ) |
| Offering costs allocated to Class A ordinary shares subject to possible redemption |   |   | (12,706,476 | ) |
| Plus:                                                                              |   |   |        |   |
| Accretion on Class A ordinary shares subject to possible redemption amount         |   |   | 32,256,476  |   |
|                                                                               |   |   |        |   |
| Class A ordinary shares subject to possible redemption                             |   | $      | 234,600,000 |   |

----

Table                  of Contents

----

Table                  of Contents

|  | • | in whole and not in part; |
|--|---------|---------------------------|
|  | • | at a price of $0.01 per warrant; |
|--|---------|----------------------------------|
|  | • | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
|--|---------|-------------------------------------------------------------------------------------------------|
|  | • | if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending                  on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table                  of Contents

|  | • | in whole and not in part; |
|--|---------|---------------------------|
|  | • | at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and                  receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 10 trading days within a 20-trading day period ending on the third trading day                  prior to the date on which the Company sends the notice of redemption to the warrant holders; and; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|  | • | if the closing price of the Class A ordinary shares for any 10 trading days within a 20-trading day period ending on the third trading day prior to the date on which the Company sends the notice of                  redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above. |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Description                                     |   | Level 1 |        |   | Level 2 |   |   | Level 3 |   |
|-------------------------------------------------|--------|---------|-------------|--------|---------|--------|--------|---------|--------|
| Assets:                                         |   |    |        |   |    |   |   |    |   |
| Investments held in Trust Account               |   | $       | 234,600,723 |   |    | $      | -      |    |   | $ | - |   |
|                                            |   |    |        |   |    |   |   |    |   |   |   |   |
| Liabilities:                                    |   |    |        |   |    |   |   |    |   |   |   |   |
| Derivative liabilities – Public Warrants  |   | $       | -           |   |    | $      | -      |    |   | $ | 7,636,000 |   |
| Derivative liabilities – Private Warrants |   | $       | -           |   |    | $      | -      |    |   | $ | 7,504,000 |   |

----

Table                  of Contents

|                                                |   | December 31, 2021 |   |   | December 13, 2021 |   |
|-----------------------------------------------------|--------|-------------------|--------|--------|-------------------|--------|
| Exercise price                                      |   | $                 | 11.50  |   |              | $      | 11.50 |   |
| Stock price                                         |   | $                 | 9.67   |   |              | $      | 9.29 |   |
| Volatility                                          |   |              | 13.0   | %      |              |   | 25.0 | % |
| Risk-free rate                                      |   |              | 1.53   | %      |              |   | 1.31 | % |
| Dividend yield                                      |   |              | 0.0    | %      |              |   | 0.0 | % |
| Years to expected initial Business Combination date |   |              | 0.94   |   |              |   | 1.00 |   |
| Years to expiration                                 |   |              | 5      |   |              |   | 5 |   |
| Derivative warrant liabilities as of March 8, 2021 (inception) |   | $      | —     |   |
|----------------------------------------------------------------|--------|--------|-------------|--------|
| Issuance of Public Warrants and Private Placement Warrants     |   |   | 30,518,000  |   |
| Change in fair value of derivative warrant liabilities         |   |   | (15,378,000 | )      |
| Balance as of December 31, 2021                                |   | $      | 15,140,000  |   |

----